| Application no. and date | 17000383.4 (espacenet) (Federated) (European Patent Register), 20120712 | | Patent/reg. no. and date | DK/EP 3246070, 20240320 | | Publication date | 20171122 | | Priority no. and date | US 201161507153 P, 20110713, EP 11005722, 20110713 | | EP pub. no. and date |
EP 3246070 20171122 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | V472900DK00 | | Inventor | Kremoser, Claus, Gugenmusweg 20
69121 Heidelberg, DE,
KINZEL, Olaf, Am Hackteufel 8
69117 Heidelberg, DE,
Steeneck, Christoph, c/o Phenex Pharmaceuticals AG
Donnersbergweg 1
67059 Ludwigshafen, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/42 (2006.01) , A61P 1/16 (2006.01) , A61P 3/10 (2006.01) , A61P 35/00 (2006.01) , C07D 261/08 (2006.01) , C07D 413/12 (2006.01) , C07D 413/14 (2006.01) | | Title | Nye azoler til modulering af FXR-(NR1H4)-binding og -aktivitet | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
